2024 annual financial data

Anika Therapeutics 2024 Operating margin

Direct answer

Operating margin was -4.25%.

Operating income was -5.1M USD and net income was -56.39M USD.
Operating cash flow was 5.4M USD.

Get free Anika Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
119.91M USD
Operating income
-5.1M USD
Net income
-56.39M USD
Operating cash flow
5.4M USD